VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1651931
Sex: F
Age:
State: AR

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Very shortly after receiving the injection, my right arm/hand went numb and I had the feeling of pins and needles.; Very shortly after receiving the injection, my right arm/hand went numb and I had the feeling of pins and needles.; Very shortly after receiving the injection, my right arm/hand went numb and I had the feeling of pins and needles. The sensation traveled up my right shoulder, my neck, and made my scalp feel the numb/tingly.; Very shortly after receiving the injection, my right arm/hand went numb and I had the feeling of pins and needles. The sensation traveled up my right shoulder, my neck, and made my scalp feel the numb/tingly.; Very shortly after receiving the injection, my right arm/hand went numb and I had the feeling of pins and needles. The sensation traveled up my right shoulder, my neck, and made my scalp feel the numb/tingly.; Shortly after my right cheek/jawline went numb/tingly.; I also started cramping severely several hours later and started my period over a week early which is VERY abnormal for me as my periods have been like clockwork for years; I also started cramping severely several hours later and started my period over a week early which is VERY abnormal for me as my periods have been like clockwork for years; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FW0179) via an unspecified route of administration in the right arm on 14May2021 at 12:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks prior to vaccination included rizatriptan benzoate 10 milligram (MAXALT), ibuprofen (MANUFACTURER UNKNOWN) and topiramate 75 milligram (MANUFACTURER UNKNOWN) all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 12:45, very shortly after receiving the injection, the patients right arm/hand went numb and she had the feeling of pins and needles. The sensation traveled up her right shoulder, her neck, and made her scalp feel the numb/tingly. Shortly after on 14May2021, the patients right cheek/jawline went numb/tingly. On 14May2021, the patient also experienced cramping severely several hours later and started her period over a week early which was very abnormal for her as her periods had been like clockwork for years. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events right arm/hand went numb and had the feeling of pins and needles, the sensation traveled up right shoulder, neck, and made scalp feel the numb/tingly, right cheek/jawline went numb/tingly, cramping severely several hours later and started period over a week early was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MAXALT; IBUPROFEN; TOPIRAMATE

Current Illness:

ID: 1651932
Sex: F
Age:
State: NJ

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210515; Test Name: Body temperature; Result Unstructured Data: Test Result: 38.3 Centigrade.

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: fever of 38.3 Celsius; almost tennis ball size swelling of right under armpit; tingling and numbness in fingers/hand/some numbness right finger; tingling and numbness in fingers/hand; swelling of wrist; Chills; sweat; fatigue; no energy; Swollen upper arm, very painful; Swollen upper arm, very painful; pain also in former injection site for first dose; whole body sore; chest tightness; swelling left lymph node under armpit; tenderness of lymph node at right collar bone; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EW0182) via an unspecified route of administration in right arm on 14May2021 11:00 AM (age at vaccination 53-year-old) as dose 2 single, for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history included exercise and allergy induced asthma (mild). Patient was not pregnant at time of vaccination. Known allergies were none. No other vaccine in four weeks. The patient's concomitant medications in two weeks were none. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0161) on left arm on 23Apr2021 11:00 (age at 53-year-old) as dose 1 single for COVID-19 Immunization and 10 min after injection, patient experienced tingling in left hand/fingers, dizziness, and slight swelling of left wrist. Dizziness gone after 30 min. Chills and sweat (no measurable fever) during the night, general fatigue and ill feeling one day after vaccine. Swollen, painful lymph node under left arm (lasting about 2 weeks). It was reported that 5 min after injection on 14May2021 11:05 AM patient had tingling and numbness in fingers/hand, swelling of wrist. Chills and sweats (no fever), lasting through the night. Swollen upper arm, very painful, pain also in former injection site of first dose, whole body sore. Some chest tightness. Next morning body/arm soreness significantly better, still chills and sweats (no fever), almost tennis ball size swelling of right under armpit and tenderness of lymph node at right collar bone as well as slight swelling left lymph node under armpit. Fatigue, no energy, some numbness right finger. 29 h after injection on 15May2021 16:00, fever of 38.3 Celsius, lasting through the night. No treatment received for adverse events. No covid prior vaccination. No covid tested post vaccination. The outcome of all events was unknown. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1651933
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Injection site pain; Sore arm for 2 plus days; Tiredness for 3 days; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced injection site pain, sore arm for 2 plus days and tiredness for 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site pain, sore arm for 2 plus days and tiredness for 3 days was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1651934
Sex: F
Age:
State: ME

Vax Date: 04/24/2021
Onset Date: 05/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Sharp pains in right temple area/ right side and shooting pain radiating from jaw area to ear to right temple; Over several days I have developed a sore throat on right side and shooting pain radiating from jaw area to ear to right temple; I have swollen lymph nodes; Severe fatigue; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CW0167) via an unspecified route of administration in the Left arm on 24Apr2021 at 11:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8737) via an unspecified route of administration in the right arm on 27Mar2021 (at the age of 55 -years-old) as a single dose for COVID-19 immunisation. On 13May2021 the patient experienced sharp pains in right temple area. Over several days she had developed a sore throat on right side and shooting pain radiating from jaw area to ear to right temple. She had swollen lymph nodes, severe fatigue, and brain fog. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events sharp pains in right temple area. Over several days she had developed a sore throat on right side and shooting pain radiating from jaw area to ear to right temple. She had swollen lymph nodes, severe fatigue, and brain fog were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651935
Sex: F
Age:
State: FL

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Mild sore throat; Arm pain at injection site; Muscle soreness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 12:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 13:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15May2021, the patient experienced mild sore throat, arm pain at injection site, muscle soreness and fatigue. It was reported that the events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events mild sore throat, arm pain at injection site, muscle soreness and fatigue were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651936
Sex: M
Age:
State: CO

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Sweats; Chills; Fever; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 12May2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, COVID-19 infection. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN), sulfa (sulfonamide) and cefaclor (CECLOR). The concomitant medication included cannabis sativa (CANNABIS) for an unknown indication, from unspecified date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12May2021 at 18:00, the patient experienced chills, sweats, fever, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events chills, sweats, fever, headache and fatigue resolved with sequelae on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: CANNABIS

Current Illness:

ID: 1651937
Sex: M
Age:
State: FL

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210510; Test Name: Curative; Test Result: Negative

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: I had a metallic taste in my mouth for about 5 days after the second dose of Pfizer vaccine. More specifically towards the back of my throat; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 07May2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included lyme disease since unknown date. The patient had no known allergies. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Apr2021 at 09:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08May2021 the patient felt metallic taste in mouth for about 5 days more specifically towards the back of throat. This did not affect taste, and it did not involve the tongue or gums. It seems to have started wearing off after 5 days or so. On 10May2021, the patient underwent COVID-19 virus test (Curative) and the results was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of the event metallic taste in mouth for about 5 days more specifically towards the back of throat was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651938
Sex: F
Age:
State:

Vax Date: 05/13/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Hot flashes; Body aches; Low energy; Chills; Headache; Lymph node swelling on armpit, neck, and elbow; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 13May2021 as a single dose for COVID-19 immunisation. Medical history included no health issues. The patient had no known allergies. The patient received unspecified medication for birth control within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 22Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced chills, hot flashes, headache, body aches, low energy and lymph node swelling on armpit, neck, and elbow at the same side of the shot. It was unknown whether therapeutic measure was taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, hot flashes, headache, body aches, low energy, lymph node swelling on armpit, neck and elbow was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651939
Sex: M
Age:
State: OR

Vax Date: 05/13/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: acute pruritic hands.; scalp and upper body was quite itchy; face red; eyes bloodshot; measles like bumps on back and back of my upper arms.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the left arm on 13May2021 at 19:30 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included rash on left hand for well over a year and had been through 3 dermatologists (no help at all) and also reported that the patient had no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 16Apr2021 at 16:30 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 01:00, after approximately 36hrs after injection the patient woke up mid-sleep and experienced acute pruritic hands quite severe sensation, after a few minutes with my hands under cold running water the patient`s scalp and upper body was quite itchy, face red, eyes bloodshot, measles like bumps on back and back of upper arms. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of acute pruritic hands quite severe sensation, scalp and upper body was quite itchy, face red, eyes bloodshot, measles like bumps on back and back of upper arms were recovered in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651940
Sex: M
Age:
State: PA

Vax Date: 05/04/2021
Onset Date: 05/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Blurry vision; Morning discharge from the eyes,; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172), via an unspecified route of administration in the left arm on 04May2021 at 09:30 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient did not have any allergies to medications, food, or other products. Concomitant medications included unspecified medication for diabetes. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021 at 08:00, the patient experienced blurry vision, morning discharge from the eyes and dizziness. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events blurry vision, morning discharge from the eyes and dizziness were not resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651941
Sex: U
Age:
State: PA

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Scratchy throat; Cough; Body aches; Fever; Chills; Headache; extreme tiredness; Stomach pain; Multiple loose stool bowel movements; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the arm left on 14May2021 at 12:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX), ubidecarenone (CO Q-10), rosuvastatin calcium (CRESTOR), progesterone (MANUFACTURER UNKNOWN) and estradiol (ESTRACE); all from unknown date for unknown indication. The patient previously took whey protein on unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 11:00 the patient experienced congestion, scratchy throat, cough, body aches, fever, chills, headache, extreme tiredness, stomach pain, multiple loose stool bowel movements. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events congestion, scratchy throat, cough, body aches, fever, chills, headache, extreme tiredness, stomach pain, multiple loose stool bowel movements were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]; CO Q-10; CRESTOR; PROGESTERONE; ESTRACE

Current Illness:

ID: 1651942
Sex: F
Age:
State: VA

Vax Date: 05/16/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Immediate rash/welts about 2 inches above and 1 inch below and around the injection site; Immediate rash/welts about 2 inches above and 1 inch below and around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16May2021 at 09:15 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included lactose intolerance. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), fiber pills, and probiotic taken for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 09:15, the patient experienced immediate rash/welts about 2 inches above and 1 inch below and around the injection site. It happened within seconds of receiving the vaccine and was gone about 30 minutes later. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the event immediate rash/welts about 2 inches above and 1 inch below and around the injection site was recovered on 16May2021 at 09:45. No follow-up attempts are needed. No further information is expected.

Other Meds: VYVANSE

Current Illness:

ID: 1651943
Sex: F
Age:
State: CT

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Arm swelled at injection site; Injection site appeared to leak fluid; This is a spontaneous report from a contactable consumer. A 31-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 11May2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021, the patient experienced arm swelled at injection site and appeared to leak fluid. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events arm swelled at injection site and appeared to leak fluid recovered on an unspecified date in May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651944
Sex: F
Age:
State: PA

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: body temperature; Result Unstructured Data: Test Result:101 Fahrenheit

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Rash; Sweating; Vomiting; high fever; arm is still hurting her; Dizziness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 53-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot number: EW0171) via an unspecified route of administration, administered in right arm on 22Apr2021 13:55 as single dose for covid-19 immunisation. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot number: EW0176) via an unspecified route of administration, administered in her left arm on 13May2021 15:00 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 23Apr2021, the patient experienced dizziness and the day after she got the first shot was when her arm started killing her and also stated it has improved but if she pushes on her arm it still hurts. On 24Apr2021, patient experienced vomiting and high fever. On 26Apr2021, patient experienced sweating and on 28Apr2021 patient developed rash. Patient confirmed that confirmed that the symptoms started after she received the COVID 19 vaccine. The patient underwent lab test which included body temperature: 101 Fahrenheit. Therapeutic measures were taken as a result of events dizziness, rash, sweating, vomiting, high fever, arm is still hurting her. Treatment drugs included Mucinex and Tylenol. Patient stated sweating stopped last week around 01May2021 but then she got her second shot and it started back up again and is still going on. The outcome of the event dizziness, sweating and rash was not recovered and the outcome of the event high fever and vomiting was recovered on 30Apr2021 and the outcome of the event arm is still hurting her was recovering. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651945
Sex: M
Age:
State:

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Rash appeared 24 hours after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0182) via an unspecified route of administration in the left arm on 14May2021 at 18:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not take any other medications within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021, rash appeared 24 hours after injection. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of rash and included treatment with Benadryl. The clinical outcome of the event rash appeared 24 hours after injection was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651946
Sex: F
Age:
State: MA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: My face went numb 30min after injection.; Then I got pain in my head; Then I got pain in my head and neck; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 05May2021 at 13:00 (at the age of 28-year-old) as a single dose of COVID-19 immunisation. Medical history included ehlers-danlos syndrome, postural orthostatic tachycardia syndrome and hashimoto's thyroiditis. The patient had no known allergies to food, medications or other products. The patient previously took paracetamol (TYLENOL) from unknown dates for relieving pain within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 13:30 thirty minutes after injection, the patient experienced numbness in face, then she got pain in her head and neck similar to whiplash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measure was taken as a result of the reported event numbness in face. Therapeutic measures were taken as a result of the reported events pain in head and neck which included treatment with motrin and tylenol from an unknown dates. The clinical outcome of the events numbness in face, pain in head and neck lasted for 10 days and recovered with sequelae on 15May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: TYLENOL

Current Illness:

ID: 1651947
Sex: F
Age:
State: NY

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Having low grade fever, nausea, headache and fatigue; Having low grade fever, nausea, headache and fatigue; Having low grade fever, nausea, headache and fatigue; Having low grade fever, nausea, headache and fatigue; She got her period within 12 hours of getting the vaccine which was 2 weeks early; This is a spontaneous report from a contactable consumer or other non hcp. A 46-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EW0176; Expiration Date: 01May2021) via an unspecified route of administration, in Arm Left on 01May2021 15:50 (age at vaccination 46years old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration, on unspecified date as single dose for covid-19 immunisation. The patient experienced having low grade fever, nausea, fatigue on 02May2021 and headache, she got her period within 12 hours of getting the vaccine which was 2 weeks early on 01May2021. Clinical course was reported as I received my 2nd dose on 01May2021, aside from having low grade fever, nausea, headache, and fatigue that was more than usual, I also got my period within 12 hours of getting the vaccine, which was 2 weeks early. I know it's not as common. The patient received treatment for headache with Tylenol. The clinical outcome of the event was recovered in 02May2021 and another event was recovered in May2021. Therapeutic measures were taken as a result of having low grade fever, nausea, headache and fatigue. No follow-up attempts are possible. No further information expected.

Other Meds:

Current Illness:

ID: 1651948
Sex: M
Age:
State: CA

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Swollen bottom lip; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 15May2021 at 10:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and outside allergies. No concomitant medications were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16May2021 at 22:00, the patient experienced swollen bottom lip. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event swollen bottom lip was recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651949
Sex: F
Age:
State: SC

Vax Date: 03/17/2021
Onset Date: 04/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210406; Test Name: Elevated liver enzymes; Result Unstructured Data: Test Result:Elevated liver enzymes; Test Date: 20210406; Test Name: Thyroid Test; Result Unstructured Data: Test Result:Abnormal Thyroid lab values

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Elevated liver enzymes; liver cysts; Abnormal Thyroid lab values; chest pain; abdominal pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6207) via an unspecified route of administration in the left arm on 17Mar2021 at 16:00 and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer in 2015. The patient previously took sumatriptan (IMITREX) for unknown indication and from unknown date and experienced allergy. Concomitant medications included pravastatin sodium (PRAVASTATINE), colecalciferol (VITAMIN D) and ibuprofen (MOTRIN) ; all from an unknown date, for an unknown indication, unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021, at 04:00 the patient experienced elevated liver enzymes, liver cysts, abnormal thyroid lab values, chest and abdominal pain. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events which included treatment with medications (not specified). The clinical outcome of the events of elevated liver enzymes, liver cysts, abnormal thyroid lab values, chest and abdominal pain were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PRAVASTINE; VITAMIN D [COLECALCIFEROL]; MOTRIN [IBUPROFEN]

Current Illness:

ID: 1651950
Sex: F
Age:
State:

Vax Date: 05/16/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Joint Pain; Chills; Fever; Tiredness; Feeling Unwell; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration on 16May2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Other vaccines within four weeks prior to the vaccination was not reported. On 16May2021, the patient experienced joint pain, chills, fever, tiredness, feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events joint pain, chills, fever, tiredness, feeling unwell was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651952
Sex: F
Age:
State: IN

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: muscle aches/ severe muscle aches; fever; chills; worse fatigue/ exhaustion/ tired; mostly slept; sore arm; This is a spontaneous report from a contactable other healthcare professional (patient). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), intramuscular, administered in the right deltoid on 21Jan2021, at 10:00 (Batch/Lot Number: EL9261, Expiration Date: May2021, at the age of 49 years old) as dose 2, single for COVID-19 immunisation. Since early Apr2020, the patient spent 4-6 hours/day face-to-face with COVID patients for months. After starting work on COVID unit, she previously had mild illness, sore throat, fatigue, achey, but no cough, and fever not over 99 from 09Apr2020 to 17Apr2021. Unknown if she had COVID. She kept working in the COVID unit per requirements at that time. On 29Dec2020, she had COVID antibody test: negative. The patient's concomitant medications were not reported. She did not have prior vaccinations. The patient previously received first dose of BNT162B2 (Batch/Lot Number: EJ1685, Expiration Date: Mar2021), intramuscular, administered in the right deltoid on 31Dec2020 (at the age of 49 years old) for COVID-19 immunisation. On 21Jan2021, at 14:00, the patient experienced muscle aches (also reported as severe muscle aches), fever for 3-4 days, chills, worse fatigue/exhaustion, mostly slept for 2-3 days, sore arm, and tired- 1 week. No therapeutic measures were taken as a result of the events and the patient just rested. The patient recovered from the events on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651953
Sex: F
Age:
State: IN

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Sharp pain in her left arm where the injection/immense pain where shot was given; sciatica in the entire left side; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in the left arm on 27Apr2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Caller stated that from 28Apr2021 she had a sharp pain in her left arm where the injection was given and sciatica in the entire left side. The caller went to her chiropractor but needed something stronger, so she went and saw her primary care provider. The caller's primary care provider put the caller on steroids- methylprednisolone, the generic for Mediprol. The caller finished the steroid on 17May2021 and was scheduled for her second dose on 18May2021. The patient was on steroid so she knew it decreases the inflammation and wanted to know how long she should wait for the second dose of vaccine. The caller's pharmacist said nothing was going to happen to the caller after the second dose. The outcome of the events was unknown. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1651954
Sex: M
Age:
State: MN

Vax Date: 05/15/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: chest pain similar to heart burn.; high fever; headache; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 15May2021 at 12:00 (at the age of 32-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported and the patient did not have a history of allergies to any food or medications or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 17May2021 at 00:00, about 36 hours after second vaccination shot the patient started to have chest pain similar to heart burn, high fever and headache for the last 30 hours as well. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chest pain similar to heart burn, high fever and headache were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1651955
Sex: F
Age:
State: TX

Vax Date: 02/18/2021
Onset Date: 02/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Vaccine caused old dance injury to become inflamed; was in able to walk for two weeks; Pain still resides; causes inability to reform task; This is a spontaneous report from a contactable healthcare professional, the patient. This 22-year-old non-pregnant female patient reported for herself that she received the second dose of BNT162B2 (PFIZER-BIONTECH COBVID-19 mRNA vaccine, lot number: EL9267) via unspecified route in the left arm on 18Feb2021 at 07:30 as a single dose for COVID-19 immunization. Medical history included old dance injury. There were no concomitant medications. Past drug history included allergy to cephalexin (CEPHEX). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not have COVID-19 prior to vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COBVID-19 mRNA vaccine, lot number: EL9264) via unspecified route on 30Jan2021 at 11:00 (at the age of 22-years-old) as a single dose in the left arm for COVID-19 immunization. On 20Feb2021, vaccine caused old dance injury to become inflamed and patient was unable to walk for two weeks. Pain still resides and causes inability to perform task. The events resulted in doctor or other healthcare professional office/clinic visit. Treatment received included Cortisone shot. The clinical outcome of the events 'old dance injury to become inflamed and patient was unable to walk for two weeks' was recovered with sequel (reported as recovered with lasting effects), while for 'Pain still resides and causes inability to perform task' was not recovered. The patient was not tested for COVID-19 post vaccination.; Sender's Comments: based on the temporal relationship the causality between the events inflammation , pain ,unable to walk and the suspect vaccine comirnaty cannot be completely ruled out The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1651956
Sex: F
Age:
State: NY

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210511; Test Name: BP shot; Result Unstructured Data: Test Result:153/110; Test Date: 20210511; Test Name: Tachycardic (HR in 140s); Result Unstructured Data: Test Result:HR in 140s

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: getting very itchy across the back of my neck; this quickly spread across the rest of my body/ itching everywhere; skin was blotchy and a systemic reaction was kicking in; felt a burning sensation all over my skin; A rash and hives spread; A rash and hives spread; got very dizzy and lightheaded; tachycardic (HR in 140s); BP shot to 153/110; very high for me; fingers became very red; fingers became very red and warm to touch, as were other parts of my skin; felt altogether awful; throat began to feel "funny" (hard to describe); I was SOB; chest pain; nausea.; Systemic reaction; This is a spontaneous report from a contactable healthcare professional (patient). This 40-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0172) via an unspecified route of administration on 11May2021 at 16:15 (at the age of 40-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included irritable bowel syndrome (IBS), migraines, asthma, gastrointestinal (GI) bleeds, depression, anaphylaxis, and allergy to DURAPORE medical tape. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications were not reported. The patient previously received diphenhydramine (BENADRYL); metoclopramide (REGLAN); codeine; tramadol; and oxycodone, paracetamol (PERCOCET) from unknown dates for unknown indications and experienced allergy. On 11May2021 at 16:30 (also reported as within 10 minutes of the vaccine) the patient experienced itchy, skin was blotchy, systemic reaction, burning sensation, rash, hives, dizzy, lightheaded, tachycardic, high blood pressure, fingers red and warm, felt altogether awful, throat felt funny, short of breath, chest pain, and nausea. The events were reported as non-serious. The patient was not hospitalized for the events. The patient visited an emergency room/department or urgent care and a doctor or other healthcare professional office/clinic as a result of the events. The clinical course was within 10 minutes of receiving the vaccine the patient began getting very itchy across the back of her neck. This quickly spread across the rest of her body. Emergency medical technicians (EMTs) examined her. Her skin was blotchy and a systemic reaction was kicking in. The patient felt a burning sensation all over her skin coupled with the itching everywhere. A rash and hives spread. She got very dizzy and lightheaded. She became tachycardic (heartrate in 140s). Her blood pressure (BP) shot to 153/110; very high for her. Her fingers became very red and warm to touch, as were other parts of her skin. She felt altogether awful. About 60 minutes after the vaccine and on route to the hospital (as reported) the patient's throat began to feel funny. She was short of breath (SOB) and experienced chest pain and nausea. The patient received treatment with dexamethasone (DECADRON), prednisone, additional medications, and intravenous (IV) fluids. Diphenhydramine could not be administered because she was allergic to it and had a history of anaphylaxis. The outcomes of itchy, skin was blotchy, systemic reaction, burning sensation, rash, hives, dizzy, lightheaded, tachycardic, high blood pressure, fingers red and warm, felt altogether awful, throat felt funny, short of breath, chest pain, and nausea were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.; Sender's Comments: Based on the information currently available, The casual association between the reported events and suspected vaccine BNT162B2 cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1651957
Sex: F
Age:
State: AL

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Tiredness; Headache; Chills; Nausea; Feeling a general malaise; This is a spontaneous report from a contactable healthcare professional, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 12May2021 at 11:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient medical history included service connected veteran. The patient did not have allergies to medications, food, or other products. Concomitant medication included MULTIVITAMIN from an unknown date, for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 12May2021 at 12:00, the patient experienced tiredness, headache, chills, nausea, felt a general malaise. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events tiredness, headache, chills, nausea, felt a general malaise was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651958
Sex: F
Age:
State: OK

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: It started with the pneumonia vaccine and then the 2 covid vaccines and I lost all my hair; This is a spontaneous report from a contactable consumer or other non hcp. A 68-years-old female patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation; pneumococcal 13-val conj vac (dipht crm197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for an unspecified indication. The patient medical history and concomitant medications were not reported. The patient experienced it started with the pneumonia vaccine and then the 2 covid vaccines and i lost all my hair (alopecia) on an unspecified date with outcome of unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1651959
Sex: F
Age:
State: IA

Vax Date: 05/05/2021
Onset Date: 05/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 46-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 46, via an unspecified route of administration, left arm, on May 5, 2021, at 13:00, single dose, for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food or other products. Concomitant medications included Drospirenone/ethinyl-estradiol and trazodone 25mg; both from unknown dates for unspecified indications. Prior to the vaccination, patient diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On May 8, 2021, at 01:30, patient experienced vomiting. No therapeutic measures taken as a result of the event. The event did not result in doctor/other healthcare professional office/clinic visit, emergency room/department or urgent care. The outcome of vomiting recovered on an unknown date in May 2021. No follow-up attempts possible. Information about lot/batch number cannot be obtained.

Other Meds: Drospirenone/ethinyl-estradiol; Trazodone

Current Illness:

ID: 1651960
Sex: F
Age:
State: NY

Vax Date: 03/19/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the right arm on 19Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune hepatitis (AIH), mixed connective tissue disease, arthritis, hypertension (HTN), gastroesophageal reflux disease (GERD), obstructive sleep apnea syndrome (OSA), overactive bladder (OAB) and prediabetes (Pre-DM). The patient had allergy to penicillin and allergy to quinolones. The patient received unspecified medications for autoimmune AIH, HTN... within twoweeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the right arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient experienced shingles. The event shingles resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event shingles and included treatment with VALTREX, gabapentin and FLEXIRIL. The clinical outcome of the event shingles was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651961
Sex: F
Age:
State: TX

Vax Date: 04/23/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Menses onset 2 days after, 21 day cycle; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 09:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021, the patient had menses onset 2 days after, 21-day cycle. The event did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of this event. The clinical outcome of the event menses onset 2 days after, 21-day cycle was recovered on an unspecified date in May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651962
Sex: M
Age:
State:

Vax Date: 05/14/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Headache; Fatigue; Fever; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0107) via an unspecified route of administration in the arm left on 14May2021 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in May2021, the patient experienced headache, fatigue, fever, injection site pain. The clinical outcome of the events headache, fatigue, fever, injection site pain was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651963
Sex: F
Age:
State: FL

Vax Date: 05/15/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Throwing up; Diarrhea; chills; low energy; Bad taste on mouth; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ewo168) via an unspecified route of administration in the left arm on 15May2021 at 14:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included unspecified birth control pill from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On an unknown date in May2021 at 15:30, the patient experienced throwing up, diarrhea, chills, low energy and bad taste on mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of throwing up, diarrhea, chills, low energy and bad taste on mouth were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651964
Sex: F
Age:
State: AZ

Vax Date: 05/14/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Extreme headache; Chills; Fever; Body aches; Nauseous; This is a spontaneous report from a contactable other healthcare professional, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ew0167) via an unspecified route of administration in the left arm on 14May2021 at 15:45 as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfonamide allergy. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via an unspecified route of administration in the left arm on 16Apr2021 at 16:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 12:00, the patient experienced extreme headache, chills, fever, body aches and nauseous. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme headache, chills, fever, body aches and nauseous were recovered with sequelae. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651965
Sex: F
Age:
State:

Vax Date: 05/16/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Extreme headache; chills; just had a sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER3736) via an unspecified route of administration in the left arm on 16May2021 at 11:45 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. It was unknown if the patient had any known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 14:00 the patient experienced extreme headache, chills two hours after the shot. The patient was better by the next day and just had a sore arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with tylenol started from unspecified date. The clinical outcome of the events extreme headache and chills was recovered on the next day on 17May2021, while that of the event sore arm was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1651966
Sex: F
Age:
State: CA

Vax Date: 04/24/2021
Onset Date: 04/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Hives; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. it was unknown if the patient was allergic to any food, medications or other products. Concomitant medications included apremilast (OTEZLA), fish oil, tocopherol (OMEGA 3), B12, Probiotic; started on unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021, the patient experienced hives. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hives was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: OTEZLA; OMEGA 3 [FISH OIL;TOCOPHEROL]

Current Illness:

ID: 1651967
Sex: F
Age:
State: WA

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: felt like a pill is stuck in chest between trachea and lower wind pipe but haven't taken any pills.; It's very annoying; slightly pain; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 11May2021 at 15:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, from the day after the vaccine, and now a week later the patient felt like a pill was stuck in the patient's chest between her trachea and lower windpipe but had not taken any pills and it happens more in the later part of the day or after exercising. At the time of the report happened in the morning which was very annoying and slightly painful. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of events felt like a pill was stuck in the chest between the trachea and lower windpipe, annoying and slightly painful were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651968
Sex: F
Age:
State: CA

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: stomach ache; Diarrhea; shoulder pain; lower back pain; feeling unwell; body pain; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 13:45 as a single dose for COVID-19 immunisation. Medical history included leukemia from 2013 to 2018. The patient did not have allergies to medications, food, or other products. The patient did not receive any other medication within two weeks prior to vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16May2021, the patient experienced stomach ache, diarrhea, shoulder pain, lower back pain, feeling unwell and body pain. No therapeutic measures were taken as a result of the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event stomach ache, diarrhea, shoulder pain, lower back pain, feeling unwell and body pain was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651969
Sex: M
Age:
State: OH

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Hives; Itching all over; Entire body was red; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewoln6) via an unspecified route of administration in the right arm on 14May2021 at 12:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included sertraline hydrochloride (ZOLOFT) for unspecified indication from unknown date. The patient had no known allergies to medications, food or other products. The patient did not receive any vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14May2021 at 14:00, 2 hours after vaccine, the patient experienced hives, itching all over and entire body was red. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events hives, itching all over and entire body was red were recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1651970
Sex: F
Age:
State:

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Pain to the left stomach area when using the restroom; Extremely nauseous; This is a spontaneous report from a non-contactable consumer, the patient. A 14-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 15May2021 at 10:45 (at the age of 14-years-old), as a single dose for COVID-19 immunisation. The patient did not have any other medical history. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 18:45, the patient experienced extremely nauseous and pain to the left stomach area when using the restroom. It was unknown whether any therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events extremely nauseous and pain to the left stomach area when using the restroom were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651971
Sex: F
Age:
State: MA

Vax Date: 04/23/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210514; Test Name: Body temperature; Result Unstructured Data: Test Result:102.2 Units:[degF]; Comments: fever 102.2 ?F

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: headache; fever 102.2 F; chills; joint pain; muscle pain; fatigue; swollen lymph nodes; This is a spontaneous report from a contactable physician, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 23Apr2021(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included cardiac dysrhythmia (extra systoles), seasonal allergies, and known allergies to birch pollen trees and nut-bearing trees. The patient did not receive any medications within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14May2021, after receiving the second dose of the vaccine, the patient experienced headache, fever of 102.2 Degrees Fahrenheit, chills, joint pain, muscle pain, fatigue, and swollen lymph nodes. On 14May2021 body temperature was checked and it was 102.2 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with acetaminophen 325 mg (MANUFACTURER UNKNOWN) and diphenhydramine HCl 25 mg (MANUFACTURER UNKNOWN). The clinical outcome of the events headache, fever of 102.2 Degrees Fahrenheit, chills, joint pain, muscle pain, fatigue, and swollen lymph nodes were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651972
Sex: F
Age:
State:

Vax Date: 05/10/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: COVID- 19 test; Result Unstructured Data: Test Result:UNKNOWN RESULT; Comments: Nasal Swab

Allergies:

Symptom List: Pain in extremity

Symptoms: Tingling and weakness in right arm; Tingling and weakness in right arm; Extremely heavy period; Headaches; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10May2021 at 14:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as no. The patient had no known allergies to medications, food, or other products. The patient did not receive any other medication within two weeks of vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021 at 14:00, the patient experienced tingling and weakness in right arm, headaches, extremely heavy period. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. On an unknown date in 2021, post vaccination, the patient underwent COVID- 19 test via nasal swab and the result was not reported. The clinical outcome of the events tingling and weakness in right arm, headaches, extremely heavy period was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651973
Sex: F
Age:
State: NY

Vax Date: 05/10/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: On saturday it also moved down the back of my neck, into my left shoulder blade and down my arm and hand.; On saturday it also moved down the back of my neck, into my left shoulder blade and down my arm and hand.; On saturday it also moved down the back of my neck, into my left shoulder blade and down my arm and hand.; On saturday it also moved down the back of my neck, into my left shoulder blade and down my arm and hand.; By late afternoon, my entire face had a numbing tingling sensation. after a couple of days, the right side of my face is fine. The injection was one week ago today, and the left side of my face still has that numbing tingling sensation.; By late afternoon, my entire face had a numbing tingling sensation. after a couple of days, the right side of my face is fine. The injection was one week ago today, and the left side of my face still has that numbing tingling sensation.; By late afternoon, my entire face had a numbing tingling sensation. after a couple of days, the right side of my face is fine. The injection was one week ago today, and the left side of my face still has that numbing tingling sensation.; By late afternoon, my entire face had a numbing tingling sensation. after a couple of days, the right side of my face is fine. The injection was one week ago today, and the left side of my face still has that numbing tingling sensation.; I also got a series of small blisters on the inside edge of my upper lip; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 10May2021 at 09:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, overweight and heart disorder (reported as prior heart issue). Information regarding known allergies was not available. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 19Apr2021 at 09:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 16:00, by late afternoon, the patients entire face had a numbing tingling sensation. After a couple of days, the right side of her face was fine. The injection was one week ago at the time of report, and the left side of her face still had that numbing tingling sensation. On 15May2021, Saturday it also moved down the back of her neck, into her left shoulder blade and down her arm and hand. On an unknown date in May2021, the patient also got a series of small blisters on the inside edge of her upper lip. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events numbing tingling sensation on right side of face was resolved after a couple of days on an unknown date in May2021. The clinical outcome of the events numbing tingling sensation on left side of face, down the back of her neck, into her left shoulder blade and down her arm and hand, and a series of small blisters on the inside edge of her upper lip was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651974
Sex: F
Age:
State: PA

Vax Date: 05/10/2021
Onset Date: 05/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Tinnitus shrill ringing in left ear nonstop; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0175) via an unspecified route of administration in the left arm on 10May2021 at 14:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Concomitant medications included multivitamin, D3 and "2000 IUs". Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 21:00, the patient experienced tinnitus shrill ringing in left ear nonstop. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event tinnitus shrill ringing in left ear nonstop was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651975
Sex: F
Age:
State: MO

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Headache at migraine level; Pain from elbow into neck; Pain from elbow into neck and behind shoulder blade; Headache; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 03May2021 at 18:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and migraines and allergy to some chemical sensitivity. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and tizanidine hydrochloride (ZANAFLEX); from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04May2021 at 00:00, the patient experienced pain from elbow into neck and behind shoulder blade for 2 full days before subsiding and fully stopped after 5 days. Also experienced headache for a full week. First 2 days were at migraine level. Extreme fatigue has reduced, but still experiencing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of pain from elbow into neck and behind shoulder blade was resolved on 09May2021 after the duration of 5 days. The clinical outcome of the was resolved with sequelae on 11May2021 after a full week. The clinical outcome of the event headache at migraine level was resolved with sequelae on 06May2021. The clinical outcome of the event extreme fatigue was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; ZANAFLEX

Current Illness:

ID: 1651976
Sex: F
Age:
State: IN

Vax Date: 01/27/2021
Onset Date: 02/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: right upper eyelid and forehead area swelling with one papule; right upper eyelid and forehead area swelling with one papule; papule; This is a spontaneous report from a contactable other hcp. A 60-years-old female (non- pregnant) patient received bnt162b2 (BNT162B2 Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 27Jan2021 10:00 (Batch/Lot Number: EL3246) as DOSE 2, SINGLE for covid-19 immunisation (60yeras at the age of vaccination). Medical history included hyperthyroidism from an unknown date and unknown if ongoing , alopecia areata from an unknown date and unknown if ongoing , gastrooesophageal reflux disease from an unknown date and unknown if ongoing , irritable bowel syndrome from an unknown date and unknown if ongoing , osteoarthritis from an unknown date and unknown if ongoing , osteoporosis from an unknown date and unknown if ongoing , hyperlipidaemia from an unknown date and unknown if ongoing , raynaud's phenomenon from an unknown date and unknown if ongoing , herpes zoster from 15Dec2020 to an unknown date involving right upper eyelid, temple area and hairline. Concomitant medication(s) included pravastatin sodium (PRAVASTATIN NA) 20 mg taken for an unspecified indication, start and stop date were not reported; esomeprazole sodium (NEXIUM [ESOMEPRAZOLE SODIUM]) 20 mg taken for an unspecified indication, start and stop date were not reported; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) taken for an unspecified indication, start and stop date were not reported; biotin (BIOTIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took cleocin s and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. The historical vaccine include BNT162B2 (Product: Covid 19, Brand Pfizer, lot Number: EL1284, Administration Time : 10:00 AM, vaccination Location: Left arm, Dose : 01) for COVID-19 immunisation (At 60 years) on 06Jan2021. The patient experienced right upper eyelid and forehead area swelling with one papule, right upper eyelid and forehead area swelling with one papule and papule on 07Feb2021 07:00. No treatment received for the events. The outcome of the events was not resolved. Follow-up attempts are completed. No further information is expected.

Other Meds: PRAVASTATIN NA; NEXIUM [ESOMEPRAZOLE SODIUM]; VITAMIN C [ASCORBIC ACID]; BIOTIN

Current Illness:

ID: 1651977
Sex: F
Age:
State: CA

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Fatigue, headaches, muscle pain, feeling unwell, swollen lymph nodes in the side of the injection after the first dose.; Fatigue, headaches, muscle pain, feeling unwell, swollen lymph nodes in the side of the injection after the first dose.; Fatigue, headaches, muscle pain, feeling unwell, swollen lymph nodes in the side of the injection after the first dose.; Fatigue, headaches, muscle pain, feeling unwell, swollen lymph nodes in the side of the injection after the first dose.; Fatigue, headaches, muscle pain, feeling unwell, swollen lymph nodes in the side of the injection after the first dose.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration on 18Apr2021 (at the age of 40-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration on 09May2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Other medication within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced fatigue, headaches, muscle pain, feeling unwell, swollen lymph nodes in the side of the injection after the first dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fatigue, headaches, muscle pain, feeling unwell, swollen lymph nodes in the side of the injection after the first dose was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1651978
Sex: F
Age:
State:

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Numbness in face and mouth; Numbness in face and mouth area; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 14May2021, as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On 14May2021, 1 hour after the administration of second dose, the patient experienced numbness in face and mouth area. The clinical outcome of both the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1651979
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Left facial numbness lasted for the remainder of the day and the day after; Left arm soreness; general malaise; This is a spontaneous report from a contactable consumer, the patient. A 33-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161), dose 1 via an unspecified route of administration, administered in Arm Left on 15Apr2021 15:00 (at the age of 33-years-old) as a single dose for covid-19 immunization. Medical history included in vitro fertilisation from an unknown date and unknown if ongoing (undergoing egg retrieval 2 weeks prior). Concomitant medication(s) and received within 2 weeks of vaccination included vitamin d; minerals nos, vitamins nos (PRENATAL PLUS); fish oil; dexamethasone; doxycycline hydrochloride (DOXY-1). The patient did not have any allergies. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021 15:30, the patient experienced left facial numbness lasted for the remainder of the day and the day after. Left arm soreness and general malaise lasted for 36 hours after the initial vaccination. The patient did not receive any treatment. The events were reported as non-serious. Outcome of the event was recovered on an unspecified date in 2021, at the time of this report. Device Date was 17May2021. No further information expected.

Other Meds: VITAMIN D [VITAMIN D NOS]; PRENATAL PLUS; DEXAMETHASONE; DOXY-1

Current Illness:

ID: 1651980
Sex: F
Age:
State: CA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Numbness on the left side of the face; body ache; general malaise; Soreness in the left arm; This is a spontaneous report from a contactable consumer or other non health care professional. A 33-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 05May2021 17:00 (Batch/Lot Number: EW0182) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included oocyte harvest and was undergoing egg retrieval 4 weeks prior. Concomitant medication included colecalciferol (VITAMIN D [COLECALCIFEROL]), ascorbic acid, ferrous fumarate, folic acid, retinol (PRENATAL [ASCORBIC ACID;FERROUS FUMARATE;FOLIC ACID;RETINOL]), fish oil (FISH OIL) taken for an unspecified indication, start and stop date were not reported. The patient experienced numbness on the left side of the face, body ache, general malaise, soreness in the left arm (non-serious) on 05May2021 17:30. This events lasted for 24 hours. On an unknown date in May2021 the events recovered. Follow-up attempts completed. No further information expected.

Other Meds: VITAMIN D [COLECALCIFEROL]; PRENATAL [ASCORBIC ACID;FERROUS FUMARATE;FOLIC ACID;RETINOL]; FISH OIL.

Current Illness:

ID: 1651981
Sex: M
Age:
State: PA

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210504; Test Name: Body temperature; Result Unstructured Data: Test Result:101; Comments: Fever; Test Date: 20210517; Test Name: PCR Abott ID NOW; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Fever (101); chills; aches; a mild cough; started to get itchy red spots in a few places on my body; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 46-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EW0176), via an unspecified route of administration, administered in Left arm on 03May2021 12:30 pm (46-year-old at the time of vaccination) as dose 2, single for covid-19 immunisation. The patient's medical history was reported as none. The concomitant medications were reported as none. The patient received ibuprofen (IBUPROFEN) and experienced allergy. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EN6202), via an unspecified route of administration, administered in Left arm on 05Apr2021 at 12:30 pm (46-year-old at the time of vaccination) as dose 1, single for covid-19 immunisation. The patient had not received any vaccine within four weeks. The patient does not have COVID prior to vaccination. The patient was tested positive since vaccination. On 04May2021 (reported as 12:00 am), the day after vaccination, the patient experienced Fever (101), chills, aches and a mild cough. The patient also started to get itchy red spots in a few places on body. Had mild symptoms the day after the second shot and then again on Sunday 09May. The. Starting the night of 14May I started to experience more severe symptoms. Fever (101), chills, aches and a mild cough. Also, started to get itchy red spots in a few places on my body. The symptoms seem to come and go in severity, but usually worst at night. They persist as of today 17May. No treatment was received for the events. The patient underwent lab tests which included Body temperature ? 101 (fever) on 04May2021 and PCR Abott ID NOW (nasal swab) negative on 17May2021. The outcome of the events were Not recovered as of 17May. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am